An artificial intelligence-powered solution for heart failure developed at Rochester, Minn.-based Mayo Clinic has received FDA clearance.
Innovation
Hartford (Conn.) HealthCare's innovation ecosystem has helped six startups and companies develop and test their ideas.
Hospital and health system venture capital arms help provide financial investment and resources to startups. If successful, these companies have the potential to generate additional revenue for the health system.
Ochsner Ventures, the venture capital arm of New Orleans-based Ochsner Health, is among the organizations participating in a $113 million venture fund in Louisiana.
Syndax, a biopharmaceutical company focusing on cancer therapies, has announced the pricing of a $150 million public offering of common stock.
Boston Children's Hospital is partnering with PacBio to use its HiFi sequencing technology to identify rare pediatric diseases.
Peoria, Ill.-based OSF HealthCare and Chicago's Insight Hospital & Medical Center have joined the Chicago ARC collaborative that aims to make healthcare more equitable through innovation.
Hartford (Conn.) HealthCare has partnered with venture capital firm Connecticut Innovations to help launch healthcare startups.
Understanding and addressing patients' health determinants, including their genomic data, is crucial to tailoring care, improving outcomes and reducing costs — and is a key pillar of personalized medicine.
Imaging company Endoluxe has entered into a know-how agreement with Rochester, Minn.- based Mayo Clinic to research the uses of artificial intelligence and machine learning in the treatment of bladder cancer.